Bristol-Myers Squibb Company DSO Ratio 2011-2026 | BMY

Annual DSO Ratio Bristol-Myers Squibb Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
83.9	81.9	84.4	76.1	70.3	69.5	107	96.5	111	104	94.8	77.9	74.8	63.9	64.3

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
111	63.9	84

Quarterly DSO Ratio Bristol-Myers Squibb Company

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
82.6	88.9	86.1	81.8	79.8	84.9	82	80.2	-	39.1	32.7	70	-	71.7	68.9	70.7	70.1	73.6	76.6	68.5	88.3	117	112	104	89.5	95.6	95.4	108	106	109	112	110	96.5	103	104	102	91.5	96.4	94.2	86.8	72.7	78.9	79.5	80.8	69	75.4	75.7	76.7	67.1	75.3	63.3	59.3	62.6	63.9	62.9	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
117	32.7	82.8

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 215.54	-1.16 %	$ 5 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	103	$ 3.88	-1.27 %	$ 415 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 19.23	-	$ 899 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.18	-2.97 %	$ 109 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	9.68	$ 0.71	17.15 %	$ 8.13 M	Israel
CytomX Therapeutics CTMX	12.3	$ 4.24	-4.83 %	$ 585 M	USA
Cyclacel Pharmaceuticals CYCC	81.5 K	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Genmab A/S GMAB	97.9	$ 25.81	0.51 %	$ 16.6 B	Danmark
Aytu BioScience AYTU	150	$ 2.65	0.76 %	$ 16.6 M	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Eton Pharmaceuticals ETON	39.1	$ 22.97	-3.53 %	$ 618 M	USA
Exelixis EXEL	43.4	$ 41.57	0.39 %	$ 11.3 B	USA
Fortress Biotech FBIO	80.5	$ 2.92	-2.01 %	$ 60.7 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.31	-2.49 %	$ 826 M	Canada